-
CSR Summary Not Available
-
NCT03153137
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameMacitentanProduct NameOPSUMIT®Therapeutic AreaEnrollment140% Female35.0%% White78.1%
Product ClassEndothelin Receptor AntagonistSponsor Protocol NumberAC-055H301Data PartnerJohnson & JohnsonCondition StudiedCongenital Heart DiseaseMean/Median Age (Years)23.9
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available